Capital increase of Medigene AG from authorised capital against cash contributions


As already published in Wertpapier-Mitteilungen (a gazette with securities announcements), there will be a capital increase at a rate of 5:1 in the class of Medigene AG (ISIN DE000A1X3W00).

The creation of positions in the new shares is scheduled to take place in unregistered positions ("freier Meldebstand", FMB) from 21 May 2024.

Registration of shareholders in the share register

The registration of the shareholders in the issuer's share register is implemented via the depository banks by re-registration in CASCADE-RS using the re-registration type "2" (other not as purchase).


For re-registrations that are transmitted between 21 and 27 May 2024, Clearstream Banking AG1 will charge a discounted price of EUR 0.30 per position. After this time period, clients will be reimbursed accordingly.

Note about submission planning

Due to the processing capacities in the share register and in CASCADE-RS, submissions amounting to 10,000 re-registrations or more per transfer must be arranged in advance with Client Services. Within the scope of overall coordination, CBF reserves the right to reject file transfers that have not been arranged in advance.


1. This announcement is published by Clearstream Banking AG (CBF), registered office at Mergenthalerallee 61, 65760 Eschborn, Germany, registered with the Commercial Register of the District Court in Frankfurt am Main, Germany, under number HRB 7500.